Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Statement re. announcement

11 Jul 2008 13:05

RNS Number : 9056Y
Angle PLC
11 July 2008
 



ANGLE plc

11 July 2008

 

Not for release, publication or distribution in whole or in part, in or into the United States, Canada, Australia, Japan or the Republic of Ireland

 

ANGLE plc ("ANGLE" or the "Company")

 

Statement re. announcement

The Board of ANGLE notes the announcement made today by Braveheart Investment Group plc ("Braveheart"). The Board continues to hold shareholder meetings to discuss its positive Preliminary Results announced yesterday. The Board will make a formal response as soon as reasonably practicable after due consideration. The Board considers that the Braveheart announcement contains a number of factual inaccuracies.

Ends

 

Contact:

 

Andrew Newland, Chief Executive

ANGLE plc

 

+ 44 (0) 1483 295830

 

 

 

Mark Connelly/ Stewart Wallace

Collins Stewart Europe Limited

 

+ 44 (0) 207 523 8350

 

Collins Stewart Europe Limited ("Collins Stewart") which is regulated in the United Kingdom by The Financial Services Authority is acting for the Company in relation to the matters described in this announcement and is not advising any other person, and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to customers of Collins Stewart or for providing advice in relation to the matters described in this announcement.

 

Dealing disclosure requirements

Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of the Company, all "dealings" in any "relevant securities" of Braveheart or the Company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Braveheart or the Company, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Braveheart or the Company or by Braveheart or the Company or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

 

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk . 

 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in price or securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the Code, which can be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPFFLFFVDBEBBV
Date   Source Headline
11th Aug 200810:26 amRNSEPT Disclosure
28th Jul 20087:00 amRNSGrant of Options
18th Jul 20083:09 pmRNSResponse RE Angle Offer
18th Jul 20087:00 amRNSStatement re possible offer
16th Jul 20089:17 amRNSEPT Disclosure
11th Jul 20081:05 pmRNSStatement re. announcement
11th Jul 20088:10 amRNSOffer Update
25th Jun 20087:00 amRNSPreliminary Results
23rd Jun 20081:58 pmRNSFurther re notice of results
23rd Jun 20087:01 amRNSCommercialisation Agreement
23rd Jun 20087:00 amRNSInvestment in IM-Sense
16th Jun 20087:00 amRNSNotice of Results
13th Jun 200812:27 pmRNSErnst and Young Award
5th Jun 20087:00 amRNSDirectorate Change
14th Apr 20087:00 amRNSInvestment in Spiral Gateway
10th Apr 200811:15 amRNSFurther re possible offer
10th Apr 20087:00 amRNSInvestment in Cascade
9th Apr 20084:24 pmRNSPossible Offer
7th Apr 20087:00 amRNSInvestment In Conjunct
2nd Apr 20087:01 amRNSInvestment in AppShare
13th Feb 20087:00 amRNSInvestment
8th Feb 20087:00 amRNSChange of Adviser
10th Jan 20087:00 amRNSInvestment
2nd Jan 20083:38 pmRNSChange of Adviser
3rd Dec 20077:00 amRNSInterim Results
21st Nov 20078:43 amRNSNotice of Results
1st Oct 20077:01 amRNSPortfolio Company Update
13th Sep 20077:05 amRNSResult of AGM
13th Sep 20077:01 amRNSDirectorate Change
20th Aug 20077:00 amRNSInvestment
17th Aug 20077:00 amRNSNotice of AGM/Annual Report
14th Aug 20077:00 amRNSAIM Rule 26
13th Aug 20077:00 amRNSInvestment
13th Jul 20077:00 amRNSAward of Options
19th Jun 20077:01 amRNSInvestment
18th Jun 20077:01 amRNSFinal Results
18th Jun 20077:00 amRNSFund Launch
14th Jun 20077:01 amRNSInvestment
8th Jun 20077:15 amRNSNotice of Results
4th Jun 200710:44 amRNSInvestee company flotation
3rd May 20077:01 amRNSInvestment
5th Apr 20071:06 pmRNSHolding(s) in Company
5th Apr 20077:01 amRNSAcquisition
4th Apr 20078:00 amRNSHolding(s) in Company
3rd Apr 20077:01 amRNSInvestment into EctoPharma
30th Mar 20077:01 amRNSDealings Commence

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.